---
title: "Curative Biotechnology, Inc. (CUBT.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/CUBT.US/norm.md"
symbol: "CUBT.US"
name: "Curative Biotechnology, Inc."
parent: "https://longbridge.com/zh-HK/quote/CUBT.US.md"
datetime: "2026-03-13T02:24:47.273Z"
locales:
  - [en](https://longbridge.com/en/quote/CUBT.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CUBT.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CUBT.US/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/CUBT.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/CUBT.US/norm.md)


# Curative Biotechnology, Inc. (CUBT.US) — 財務報表

## 損益表 (USD)

| 指標 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0008 | -0.0011 | -0.0010 | -0.0010 | -0.0012 |
| ROE | - | - | 76.77% | - | - |
| Revenue | - | - | - | - | - |
| Net income | -764837.00 | -1.01M | -902598.00 | -882065.00 | -1.11M |
| Operating income | -509060.00 | -282539.00 | -672624.00 | -460579.00 | -761616.00 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 2.14M | 2.29M | 2.16M | - | - |
| Leverage | -0.3649 | -0.4576 | -0.4404 | - | - |
| BVPS | -0.0055 | -0.0049 | -0.0053 | - | - |
| Turnover | - | - | - | - | - |
| Cash & STI | 30740.00 | 218263.00 | 19534.00 | - | - |
| Inv & Rec | - | - | - | - | - |
| LT assets | 1367.00 | 2050.00 | 2392.00 | - | - |
| Net debt | 3.44M | 2.89M | 2.97M | - | - |

## 現金流量表 (USD)

| 指標 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | - | -185272.00 | -164807.00 | - | -261171.00 |
| Investing CF | - | - | 15000.00 | - | -15000.00 |
| Financing CF | - | 384000.00 | 132501.00 | - | 338374.00 |
| Free CF | - | - | -196784.00 | - | - |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |